Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III skin prick test of JTE-350 in healthy volunteers
jRCT2080222252Phase 3
- Sponsor
- Torii Pharmaceutical
- Start
- Oct 2013
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of JTE-350 in allergy, sponsored by Torii Pharmaceutical.
02
Drugs
JTE-350
03
Conditions
allergy
Beyond the preview
Go deeper on jRCT2080222252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222252.